Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-13

Clinical Trial Update: Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated drug interactions between dolutegravir and escalating doses of rifampicin in people with HIV and tuberculosis. The study has been c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dolutegravir (dolutegravir)
  • Rifampicin

Snippet

Sponsor: Helen Reynolds | Conditions: Hiv, Tuberculosis | Phase 4 | Status: COMPLETED